Atlas Trials

Primary Prevention Hepatocellular Carcinoma by Metformin

Clinical trial NCT02319200 · TERMINATED

Trial details

NCT number
NCT02319200
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatocellular CarcinomaHepatitis C, ChronicCirrhosis
Start date
2015-06-01
Primary completion
2016-04-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.